After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
The company is listed on the NASDAQ and operates within the Diagnostics & Research industry segment. The current market capitalization of Castle Biosciences Inc is $852.54M. A total of 0.14 million shares were traded on the day, compared to an average of 387.57K shares.
In the most recent transaction, Stokes Frank sold 6,923 shares of CSTL for 29.93 per share on Nov 15 ’24. After the transaction, the Chief Financial Officer now owns 30,823 company shares. In a previous transaction on Nov 12 ’24, MAETZOLD DEREK J sold 3,155 shares at 34.15 per share. CSTL shares that Pres. & Chief Exec. Officer owns now total 6,151.
Among the insiders who sold shares, MAETZOLD DEREK J disposed of 1,972 shares on Nov 12 ’24 at a per-share price of $34.15. This resulted in the Pres. & Chief Exec. Officer holding 87,720 shares of CSTL after the transaction. In another insider transaction, Stokes Frank bought 6,923 shares at $31.48 per share on Nov 15 ’24.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, CSTL has a high of $35.84 and a low of $16.97.
As of this writing, CSTL has an earnings estimate of $0.02 per share for the current quarter. EPS was calculated based on a consensus of 8.0 estimates, with a high estimate of $0.14 per share and a lower estimate of -$0.12. The company reported an EPS of -$0.1 in the last quarter
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. CSTL’s latest balance sheet shows that the firm has $329.63M in Cash & Short Term Investments as of fiscal 2021. There were $8.20M in debt and $24.89M in liabilities at the time. Its Book Value Per Share was $15.77, while its Total Shareholder’s Equity was $411.74M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CSTL is Buy with a score of 5.00.
